A Safety Study of Multiple Subcutaneous (s.c.) Injections of SHR-1314 in Adults With Moderate-to-severe Plaque Psoriasis

Condition:   Moderate-to-severe Plaque Psoriasis Intervention:   Biological: SHR-1314 Sponsor:   Jiangsu HengRui Medicine Co., Ltd. Recruiting

Source: ClinicalTrials.gov - October 18, 2018 Category: Research Source Type: clinical trials